Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jun 7;14(6):787-788.
doi: 10.2215/CJN.04750419. Epub 2019 May 20.

Therapeutic Potential of Newer Drugs for Treating Hyperkalemia

Matthew R Weir  1
Affiliations
Editorial

Therapeutic Potential of Newer Drugs for Treating Hyperkalemia

Matthew R Weir. Clin J Am Soc Nephrol. .
No abstract available

Keywords: Potassium; chronic kidney disease; hyperkalemia; renin angiotensin aldosterone-system inhibitors; risk factors.

PubMed Disclaimer

Comment on

References

    1. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169: 1156–1162, 2009 - PMC - PubMed
    1. Noori N, Kalantar-Zadeh K, Kovesdy CP, Murali SB, Bross R, Nissenson AR, Kopple JD: Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis 56: 338–347, 2010 - PMC - PubMed
    1. Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM: Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: A systematic review. Am J Med 126: 264.e9–264.e24, 2013 - PubMed
    1. Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators : Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 372: 211–221, 2015 - PubMed
    1. Spinowitz BS, Fishbane S, Pergola PE, Roger SD, Lerma EV, Butler J, von Haehling S, Adler SH, Zhao J, Singh B, Lavin PT, McCullough PA, Kosiborod M, Packham DK; ZS-005 Study Investigators: Sodium zirconium cyclosilicate among individuals with hyperkalemia: A 12-month phase 3 study. Clin J Am Soc Nephrol 14: 798–809, 2019 - PMC - PubMed

Substances